• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Aspirin Increases Bleeding Risk

July 20, 2012

In a study published in the Journal of the American Medical Association (JAMA), researchers found that regular use of low-dose aspirin to prevent cardiovascular events among high-risk patients may result in an increased risk of major bleeding. This study examined administrative records of 4.1 million individuals and using a matched case-control analysis, showed that aspirin use led to a greater risk of major gastrointestinal or cerebral bleeding.  Individuals with diabetes had higher risk of bleeding, independent of aspirin use


Reference:

De Berardis G, Lucisano G, D’Ettorre A, Pellegrini F, Lepore V, Tognoni G, Nicolucci A. Association of aspirin use with major bleeding in patients with and without diabetes. JAMA 2012;307: 2286-94.

Filed Under

  • Coagulation & Plasma Transfusion
  • News

Recommended

  • RBC Transfusions Improve Quality of Life for Some Patients with Cancer

  • AABB Bulletin Highlights Recommendations to Reduce the Risk of Transfusion-Related Acute Lung Injury (TRALI)

  • Human Virome Can Be Profiled with a Drop of Blood

Show Comments

Reader Interactions

Trackbacks

  1. Aspirin Increases Bleeding Risk says:
    August 8, 2012 at 3:10 am

    […] https://transfusionnews.com/2012/07/20/aspirin-increases-bleeding-risk/ […]

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Gene Editing of HBG1 and HBG2 Promotors to Treat β-Thalassemia and Sickle Cell Disease

  • Jehovah’s Witness Governing Body Allows Autologous Transfusions

  • RBC Exchange Transfusion for Patients with Severe Babesiosis

  • Oropouche Virus RNA Detected in Blood Donors in Brazil

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley